Multiple Management Modalities in Esophageal Cancer: Combined Modality Management Approaches

Mary Koshy, Natia Esiashvilli, Jerome C. Landry, Charles Thomas, Richard H. Matthew

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

The overall success rate nationally in treating esophageal carcinomas remains poor, with over 90% of patients succumbing to the disease. In part I of this two-part series, we explored epidemiology, presentation and progression, work-up, and surgical approaches. In part II, we explore the promising suggestions of integrating chemotherapy and radiation therapy into the multimodal management of esophageal cancers. Alternative approaches to resection alone have been sought because of the overall poor survival rates of esophageal cancer patients, with failures occurring both local-regionally and distantly. Concomitant chemotherapy and radiation therapy (XRT) have been shown, by randomized trial, to be more effective than XRT alone in treating unresectable esophageal cancers and also have shown promise as a neoadjuvant treatment when combined with surgery in the multimodal treatment of this disease. Various studies have also addressed issues such as preoperative chemotherapy, radiation dose escalation, chemotherapy/XRT as a definitive treatment versus use as a surgical adjuvant, and alternative chemotherapy regimens. There are suggestions of some progress, but this remains a difficult problem area in which management is continuing to evolve.

Original languageEnglish (US)
Pages (from-to)147-159
Number of pages13
JournalOncologist
Volume9
Issue number2
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Esophageal Neoplasms
Drug Therapy
Radiotherapy
Combined Modality Therapy
Neoadjuvant Therapy
Adjuvant Chemotherapy
Epidemiology
Survival Rate
Radiation
Carcinoma
Therapeutics

Keywords

  • Esophageal carcinoma
  • Multimodal treatment
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Multiple Management Modalities in Esophageal Cancer : Combined Modality Management Approaches. / Koshy, Mary; Esiashvilli, Natia; Landry, Jerome C.; Thomas, Charles; Matthew, Richard H.

In: Oncologist, Vol. 9, No. 2, 2004, p. 147-159.

Research output: Contribution to journalArticle

Koshy, Mary ; Esiashvilli, Natia ; Landry, Jerome C. ; Thomas, Charles ; Matthew, Richard H. / Multiple Management Modalities in Esophageal Cancer : Combined Modality Management Approaches. In: Oncologist. 2004 ; Vol. 9, No. 2. pp. 147-159.
@article{97bb7d80f8764847a84af40c898cdcbb,
title = "Multiple Management Modalities in Esophageal Cancer: Combined Modality Management Approaches",
abstract = "The overall success rate nationally in treating esophageal carcinomas remains poor, with over 90{\%} of patients succumbing to the disease. In part I of this two-part series, we explored epidemiology, presentation and progression, work-up, and surgical approaches. In part II, we explore the promising suggestions of integrating chemotherapy and radiation therapy into the multimodal management of esophageal cancers. Alternative approaches to resection alone have been sought because of the overall poor survival rates of esophageal cancer patients, with failures occurring both local-regionally and distantly. Concomitant chemotherapy and radiation therapy (XRT) have been shown, by randomized trial, to be more effective than XRT alone in treating unresectable esophageal cancers and also have shown promise as a neoadjuvant treatment when combined with surgery in the multimodal treatment of this disease. Various studies have also addressed issues such as preoperative chemotherapy, radiation dose escalation, chemotherapy/XRT as a definitive treatment versus use as a surgical adjuvant, and alternative chemotherapy regimens. There are suggestions of some progress, but this remains a difficult problem area in which management is continuing to evolve.",
keywords = "Esophageal carcinoma, Multimodal treatment, Survival",
author = "Mary Koshy and Natia Esiashvilli and Landry, {Jerome C.} and Charles Thomas and Matthew, {Richard H.}",
year = "2004",
doi = "10.1634/theoncologist.9-2-147",
language = "English (US)",
volume = "9",
pages = "147--159",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "2",

}

TY - JOUR

T1 - Multiple Management Modalities in Esophageal Cancer

T2 - Combined Modality Management Approaches

AU - Koshy, Mary

AU - Esiashvilli, Natia

AU - Landry, Jerome C.

AU - Thomas, Charles

AU - Matthew, Richard H.

PY - 2004

Y1 - 2004

N2 - The overall success rate nationally in treating esophageal carcinomas remains poor, with over 90% of patients succumbing to the disease. In part I of this two-part series, we explored epidemiology, presentation and progression, work-up, and surgical approaches. In part II, we explore the promising suggestions of integrating chemotherapy and radiation therapy into the multimodal management of esophageal cancers. Alternative approaches to resection alone have been sought because of the overall poor survival rates of esophageal cancer patients, with failures occurring both local-regionally and distantly. Concomitant chemotherapy and radiation therapy (XRT) have been shown, by randomized trial, to be more effective than XRT alone in treating unresectable esophageal cancers and also have shown promise as a neoadjuvant treatment when combined with surgery in the multimodal treatment of this disease. Various studies have also addressed issues such as preoperative chemotherapy, radiation dose escalation, chemotherapy/XRT as a definitive treatment versus use as a surgical adjuvant, and alternative chemotherapy regimens. There are suggestions of some progress, but this remains a difficult problem area in which management is continuing to evolve.

AB - The overall success rate nationally in treating esophageal carcinomas remains poor, with over 90% of patients succumbing to the disease. In part I of this two-part series, we explored epidemiology, presentation and progression, work-up, and surgical approaches. In part II, we explore the promising suggestions of integrating chemotherapy and radiation therapy into the multimodal management of esophageal cancers. Alternative approaches to resection alone have been sought because of the overall poor survival rates of esophageal cancer patients, with failures occurring both local-regionally and distantly. Concomitant chemotherapy and radiation therapy (XRT) have been shown, by randomized trial, to be more effective than XRT alone in treating unresectable esophageal cancers and also have shown promise as a neoadjuvant treatment when combined with surgery in the multimodal treatment of this disease. Various studies have also addressed issues such as preoperative chemotherapy, radiation dose escalation, chemotherapy/XRT as a definitive treatment versus use as a surgical adjuvant, and alternative chemotherapy regimens. There are suggestions of some progress, but this remains a difficult problem area in which management is continuing to evolve.

KW - Esophageal carcinoma

KW - Multimodal treatment

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=1842452788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842452788&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.9-2-147

DO - 10.1634/theoncologist.9-2-147

M3 - Article

C2 - 15047919

AN - SCOPUS:1842452788

VL - 9

SP - 147

EP - 159

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 2

ER -